Structure

Physi-Chem Properties

Molecular Weight:  444.16
Volume:  414.953
LogP:  -0.516
LogD:  -0.481
LogS:  -2.178
# Rotatable Bonds:  8
TPSA:  178.53
# H-Bond Aceptor:  11
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.222
Synthetic Accessibility Score:  4.525
Fsp3:  0.6
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.04
MDCK Permeability:  2.943929393950384e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.819
Human Intestinal Absorption (HIA):  0.912
20% Bioavailability (F20%):  0.815
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.214
Plasma Protein Binding (PPB):  43.95538330078125%
Volume Distribution (VD):  0.387
Pgp-substrate:  31.739234924316406%

ADMET: Metabolism

CYP1A2-inhibitor:  0.029
CYP1A2-substrate:  0.033
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.103
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.073
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.116
CYP3A4-inhibitor:  0.017
CYP3A4-substrate:  0.031

ADMET: Excretion

Clearance (CL):  1.178
Half-life (T1/2):  0.78

ADMET: Toxicity

hERG Blockers:  0.142
Human Hepatotoxicity (H-HT):  0.035
Drug-inuced Liver Injury (DILI):  0.69
AMES Toxicity:  0.487
Rat Oral Acute Toxicity:  0.037
Maximum Recommended Daily Dose:  0.001
Skin Sensitization:  0.907
Carcinogencity:  0.197
Eye Corrosion:  0.003
Eye Irritation:  0.068
Respiratory Toxicity:  0.027

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470510

Natural Product ID:  NPC470510
Common Name*:   Cinnacasolide B
IUPAC Name:   (2R,3S,4S,5R,6S)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-[(E)-3-hydroxyprop-1-enyl]phenoxy]oxane-3,4,5-triol
Synonyms:   Cinnacasolide B
Standard InCHIKey:  OBAALXPOHKOEEY-IDPVQYMJSA-N
Standard InCHI:  InChI=1S/C20H28O11/c21-7-3-5-11-4-1-2-6-12(11)30-18-16(25)15(24)14(23)13(31-18)8-28-19-17(26)20(27,9-22)10-29-19/h1-6,13-19,21-27H,7-10H2/b5-3+/t13-,14-,15+,16-,17+,18-,19-,20-/m1/s1
SMILES:  OC/C=C/c1ccccc1O[C@@H]1O[C@H](CO[C@@H]2OC[C@]([C@H]2O)(O)CO)[C@H]([C@@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2048805
PubChem CID:   70692599
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31458 Cinnamomum cassia Species Lauraceae Eukaryota twigs n.a. n.a. PMID[19555125]
NPO31458 Cinnamomum cassia Species Lauraceae Eukaryota twigs n.a. n.a. PMID[22677314]
NPO31458 Cinnamomum cassia Species Lauraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO31458 Cinnamomum cassia Species Lauraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT967 Individual Protein Xanthine dehydrogenase Homo sapiens Inhibition = 35.4 % PMID[550569]
NPT967 Individual Protein Xanthine dehydrogenase Homo sapiens IC50 > 50.0 ug.mL-1 PMID[550569]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470510 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9496 High Similarity NPC226712
0.9421 High Similarity NPC287429
0.925 High Similarity NPC469412
0.925 High Similarity NPC198734
0.925 High Similarity NPC269242
0.9147 High Similarity NPC469383
0.9127 High Similarity NPC474491
0.912 High Similarity NPC146540
0.912 High Similarity NPC40377
0.9062 High Similarity NPC25821
0.9048 High Similarity NPC97326
0.9008 High Similarity NPC60589
0.9008 High Similarity NPC469708
0.8906 High Similarity NPC166168
0.8846 High Similarity NPC87696
0.8806 High Similarity NPC472353
0.879 High Similarity NPC476142
0.8779 High Similarity NPC79957
0.8769 High Similarity NPC6836
0.875 High Similarity NPC248355
0.875 High Similarity NPC166040
0.8731 High Similarity NPC215512
0.8731 High Similarity NPC476442
0.8722 High Similarity NPC183781
0.8712 High Similarity NPC104167
0.8712 High Similarity NPC166180
0.8702 High Similarity NPC34456
0.8702 High Similarity NPC470881
0.8692 High Similarity NPC252833
0.8692 High Similarity NPC269421
0.8682 High Similarity NPC80600
0.8682 High Similarity NPC472024
0.8678 High Similarity NPC175771
0.8672 High Similarity NPC302378
0.8647 High Similarity NPC87777
0.8647 High Similarity NPC262328
0.8644 High Similarity NPC264784
0.8629 High Similarity NPC476445
0.8629 High Similarity NPC469548
0.8629 High Similarity NPC476448
0.8626 High Similarity NPC215037
0.8615 High Similarity NPC9912
0.8605 High Similarity NPC218003
0.8605 High Similarity NPC295970
0.8605 High Similarity NPC26653
0.8605 High Similarity NPC270849
0.8593 High Similarity NPC108674
0.8583 High Similarity NPC12308
0.8571 High Similarity NPC475628
0.8561 High Similarity NPC471029
0.855 High Similarity NPC303422
0.855 High Similarity NPC26080
0.855 High Similarity NPC85799
0.855 High Similarity NPC165686
0.8548 High Similarity NPC282409
0.8548 High Similarity NPC469702
0.8538 High Similarity NPC262606
0.8512 High Similarity NPC142319
0.8512 High Similarity NPC313193
0.8507 High Similarity NPC134260
0.8485 Intermediate Similarity NPC115022
0.8485 Intermediate Similarity NPC49074
0.8485 Intermediate Similarity NPC294166
0.8478 Intermediate Similarity NPC43508
0.8478 Intermediate Similarity NPC476301
0.8473 Intermediate Similarity NPC65942
0.8473 Intermediate Similarity NPC475067
0.8473 Intermediate Similarity NPC121376
0.8473 Intermediate Similarity NPC248307
0.8467 Intermediate Similarity NPC46092
0.8462 Intermediate Similarity NPC307110
0.8456 Intermediate Similarity NPC210192
0.845 Intermediate Similarity NPC198798
0.8433 Intermediate Similarity NPC103409
0.8429 Intermediate Similarity NPC169510
0.8425 Intermediate Similarity NPC470907
0.8425 Intermediate Similarity NPC232454
0.8425 Intermediate Similarity NPC178449
0.8421 Intermediate Similarity NPC187194
0.8421 Intermediate Similarity NPC476411
0.8421 Intermediate Similarity NPC251981
0.8421 Intermediate Similarity NPC48863
0.8421 Intermediate Similarity NPC13745
0.8421 Intermediate Similarity NPC188555
0.8421 Intermediate Similarity NPC130496
0.8409 Intermediate Similarity NPC299144
0.8409 Intermediate Similarity NPC162093
0.8406 Intermediate Similarity NPC283995
0.8406 Intermediate Similarity NPC217635
0.8406 Intermediate Similarity NPC129417
0.8406 Intermediate Similarity NPC470235
0.8406 Intermediate Similarity NPC471667
0.8406 Intermediate Similarity NPC79429
0.8394 Intermediate Similarity NPC145319
0.8394 Intermediate Similarity NPC245219
0.8394 Intermediate Similarity NPC230718
0.8394 Intermediate Similarity NPC475084
0.8394 Intermediate Similarity NPC84207
0.8394 Intermediate Similarity NPC128337
0.8394 Intermediate Similarity NPC31081
0.8394 Intermediate Similarity NPC49542
0.8394 Intermediate Similarity NPC5253
0.8394 Intermediate Similarity NPC139976
0.8387 Intermediate Similarity NPC228907
0.8374 Intermediate Similarity NPC148055
0.8372 Intermediate Similarity NPC171533
0.837 Intermediate Similarity NPC470413
0.837 Intermediate Similarity NPC138738
0.837 Intermediate Similarity NPC195196
0.8361 Intermediate Similarity NPC157338
0.8358 Intermediate Similarity NPC185778
0.8358 Intermediate Similarity NPC238243
0.8357 Intermediate Similarity NPC15956
0.8357 Intermediate Similarity NPC31325
0.8357 Intermediate Similarity NPC224674
0.8357 Intermediate Similarity NPC193473
0.8357 Intermediate Similarity NPC275284
0.8357 Intermediate Similarity NPC296377
0.8357 Intermediate Similarity NPC213074
0.8357 Intermediate Similarity NPC114505
0.8346 Intermediate Similarity NPC471067
0.8346 Intermediate Similarity NPC215833
0.8346 Intermediate Similarity NPC69513
0.8345 Intermediate Similarity NPC18979
0.8345 Intermediate Similarity NPC469586
0.8333 Intermediate Similarity NPC470950
0.8333 Intermediate Similarity NPC252169
0.8333 Intermediate Similarity NPC242756
0.8333 Intermediate Similarity NPC116922
0.8333 Intermediate Similarity NPC185307
0.831 Intermediate Similarity NPC98624
0.8306 Intermediate Similarity NPC9248
0.8296 Intermediate Similarity NPC203230
0.8296 Intermediate Similarity NPC172818
0.8296 Intermediate Similarity NPC197723
0.8296 Intermediate Similarity NPC164857
0.8296 Intermediate Similarity NPC138350
0.8296 Intermediate Similarity NPC3293
0.8296 Intermediate Similarity NPC37468
0.8296 Intermediate Similarity NPC165482
0.8296 Intermediate Similarity NPC242028
0.8296 Intermediate Similarity NPC40664
0.8296 Intermediate Similarity NPC25695
0.8295 Intermediate Similarity NPC90318
0.8286 Intermediate Similarity NPC112861
0.8284 Intermediate Similarity NPC35731
0.8273 Intermediate Similarity NPC168579
0.8273 Intermediate Similarity NPC469313
0.8273 Intermediate Similarity NPC177597
0.8273 Intermediate Similarity NPC76176
0.8273 Intermediate Similarity NPC138227
0.8273 Intermediate Similarity NPC292443
0.8273 Intermediate Similarity NPC225445
0.8273 Intermediate Similarity NPC232228
0.8268 Intermediate Similarity NPC57751
0.8261 Intermediate Similarity NPC253878
0.8261 Intermediate Similarity NPC246947
0.8261 Intermediate Similarity NPC476356
0.8261 Intermediate Similarity NPC164599
0.825 Intermediate Similarity NPC276061
0.825 Intermediate Similarity NPC474148
0.8248 Intermediate Similarity NPC106944
0.8244 Intermediate Similarity NPC87224
0.8244 Intermediate Similarity NPC222572
0.8235 Intermediate Similarity NPC59324
0.8235 Intermediate Similarity NPC477797
0.8235 Intermediate Similarity NPC477798
0.8235 Intermediate Similarity NPC304152
0.8235 Intermediate Similarity NPC194034
0.8235 Intermediate Similarity NPC65530
0.8235 Intermediate Similarity NPC124149
0.8231 Intermediate Similarity NPC233559
0.8227 Intermediate Similarity NPC469700
0.8227 Intermediate Similarity NPC474422
0.8222 Intermediate Similarity NPC174191
0.8222 Intermediate Similarity NPC55040
0.8222 Intermediate Similarity NPC470236
0.822 Intermediate Similarity NPC152384
0.822 Intermediate Similarity NPC37714
0.8214 Intermediate Similarity NPC226722
0.8214 Intermediate Similarity NPC22150
0.8214 Intermediate Similarity NPC279298
0.8214 Intermediate Similarity NPC38041
0.8214 Intermediate Similarity NPC138915
0.8214 Intermediate Similarity NPC475096
0.8214 Intermediate Similarity NPC85624
0.8209 Intermediate Similarity NPC132895
0.8203 Intermediate Similarity NPC52097
0.8201 Intermediate Similarity NPC81638
0.8201 Intermediate Similarity NPC37793
0.8195 Intermediate Similarity NPC478255
0.8195 Intermediate Similarity NPC162801
0.8189 Intermediate Similarity NPC469704
0.8189 Intermediate Similarity NPC201402
0.8189 Intermediate Similarity NPC160854
0.8189 Intermediate Similarity NPC473875
0.8189 Intermediate Similarity NPC469703
0.8189 Intermediate Similarity NPC475529
0.8188 Intermediate Similarity NPC471414
0.8188 Intermediate Similarity NPC5155

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470510 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9496 High Similarity NPD1091 Approved
0.8235 Intermediate Similarity NPD290 Approved
0.7887 Intermediate Similarity NPD5058 Phase 3
0.7862 Intermediate Similarity NPD1653 Approved
0.776 Intermediate Similarity NPD7843 Approved
0.7737 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD1613 Approved
0.7724 Intermediate Similarity NPD2684 Approved
0.763 Intermediate Similarity NPD2861 Phase 2
0.7615 Intermediate Similarity NPD1357 Approved
0.76 Intermediate Similarity NPD8455 Phase 2
0.7578 Intermediate Similarity NPD7157 Approved
0.7578 Intermediate Similarity NPD6671 Approved
0.7576 Intermediate Similarity NPD3705 Approved
0.7566 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD968 Approved
0.7552 Intermediate Similarity NPD6674 Discontinued
0.7538 Intermediate Similarity NPD1548 Phase 1
0.7518 Intermediate Similarity NPD7033 Discontinued
0.7518 Intermediate Similarity NPD5588 Approved
0.7447 Intermediate Similarity NPD7097 Phase 1
0.7445 Intermediate Similarity NPD4908 Phase 1
0.7445 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD1610 Phase 2
0.7431 Intermediate Similarity NPD1652 Phase 2
0.7424 Intermediate Similarity NPD5126 Approved
0.7424 Intermediate Similarity NPD5125 Phase 3
0.7413 Intermediate Similarity NPD7266 Discontinued
0.7407 Intermediate Similarity NPD8651 Approved
0.7391 Intermediate Similarity NPD3027 Phase 3
0.7372 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD2424 Discontinued
0.7338 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4749 Approved
0.7324 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD4538 Approved
0.7324 Intermediate Similarity NPD4536 Approved
0.731 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD5124 Phase 1
0.7305 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD3818 Discontinued
0.7292 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6002 Phase 3
0.7292 Intermediate Similarity NPD6004 Phase 3
0.7292 Intermediate Similarity NPD5762 Approved
0.7292 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6005 Phase 3
0.7292 Intermediate Similarity NPD5763 Approved
0.7273 Intermediate Similarity NPD5960 Phase 3
0.7266 Intermediate Similarity NPD969 Suspended
0.7254 Intermediate Similarity NPD6653 Approved
0.7239 Intermediate Similarity NPD3496 Discontinued
0.7236 Intermediate Similarity NPD291 Approved
0.7222 Intermediate Similarity NPD6559 Discontinued
0.7214 Intermediate Similarity NPD6798 Discontinued
0.7214 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD3685 Discontinued
0.7203 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD9365 Approved
0.7185 Intermediate Similarity NPD422 Phase 1
0.7183 Intermediate Similarity NPD6355 Discontinued
0.7164 Intermediate Similarity NPD1778 Approved
0.7164 Intermediate Similarity NPD5846 Approved
0.7164 Intermediate Similarity NPD6516 Phase 2
0.7163 Intermediate Similarity NPD6233 Phase 2
0.7153 Intermediate Similarity NPD3225 Approved
0.7153 Intermediate Similarity NPD6696 Suspended
0.7143 Intermediate Similarity NPD7054 Approved
0.7143 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD3179 Approved
0.7143 Intermediate Similarity NPD3180 Approved
0.7143 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD2231 Phase 2
0.7132 Intermediate Similarity NPD2235 Phase 2
0.7113 Intermediate Similarity NPD4060 Phase 1
0.7109 Intermediate Similarity NPD556 Approved
0.7099 Intermediate Similarity NPD7074 Phase 3
0.7099 Intermediate Similarity NPD7472 Approved
0.7095 Intermediate Similarity NPD2677 Approved
0.7092 Intermediate Similarity NPD1048 Approved
0.7089 Intermediate Similarity NPD7199 Phase 2
0.7086 Intermediate Similarity NPD5403 Approved
0.7078 Intermediate Similarity NPD37 Approved
0.7067 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4340 Discontinued
0.7055 Intermediate Similarity NPD6797 Phase 2
0.7051 Intermediate Similarity NPD4965 Approved
0.7051 Intermediate Similarity NPD4967 Phase 2
0.7051 Intermediate Similarity NPD4966 Approved
0.705 Intermediate Similarity NPD558 Phase 2
0.705 Intermediate Similarity NPD5647 Approved
0.7044 Intermediate Similarity NPD3787 Discontinued
0.7027 Intermediate Similarity NPD4628 Phase 3
0.7012 Intermediate Similarity NPD7251 Discontinued
0.6978 Remote Similarity NPD6362 Approved
0.6978 Remote Similarity NPD1794 Approved
0.6975 Remote Similarity NPD7228 Approved
0.697 Remote Similarity NPD7808 Phase 3
0.697 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6962 Remote Similarity NPD6234 Discontinued
0.6954 Remote Similarity NPD5401 Approved
0.6953 Remote Similarity NPD1358 Approved
0.6948 Remote Similarity NPD4380 Phase 2
0.6947 Remote Similarity NPD821 Approved
0.6947 Remote Similarity NPD1138 Approved
0.6939 Remote Similarity NPD1375 Discontinued
0.6933 Remote Similarity NPD3122 Phase 3
0.6929 Remote Similarity NPD9697 Approved
0.6929 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6928 Remote Similarity NPD8312 Approved
0.6928 Remote Similarity NPD8313 Approved
0.6923 Remote Similarity NPD3162 Approved
0.6923 Remote Similarity NPD3163 Approved
0.6923 Remote Similarity NPD4062 Phase 3
0.6894 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6887 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6887 Remote Similarity NPD1774 Approved
0.6879 Remote Similarity NPD5402 Approved
0.6879 Remote Similarity NPD3018 Phase 2
0.6875 Remote Similarity NPD3597 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2238 Phase 2
0.6871 Remote Similarity NPD3751 Discontinued
0.6871 Remote Similarity NPD6032 Approved
0.687 Remote Similarity NPD228 Approved
0.687 Remote Similarity NPD1137 Approved
0.687 Remote Similarity NPD1139 Approved
0.6857 Remote Similarity NPD2797 Approved
0.6846 Remote Similarity NPD5062 Approved
0.6846 Remote Similarity NPD5061 Approved
0.6835 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6828 Remote Similarity NPD1933 Approved
0.6828 Remote Similarity NPD5735 Approved
0.6824 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6824 Remote Similarity NPD521 Clinical (unspecified phase)
0.6822 Remote Similarity NPD9552 Approved
0.6818 Remote Similarity NPD5535 Approved
0.6815 Remote Similarity NPD2978 Approved
0.6815 Remote Similarity NPD2977 Approved
0.6812 Remote Similarity NPD776 Approved
0.6809 Remote Similarity NPD3691 Phase 2
0.6809 Remote Similarity NPD3690 Phase 2
0.6807 Remote Similarity NPD7685 Pre-registration
0.68 Remote Similarity NPD4535 Phase 3
0.68 Remote Similarity NPD3892 Phase 2
0.68 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6792 Remote Similarity NPD7075 Discontinued
0.6791 Remote Similarity NPD2557 Approved
0.6791 Remote Similarity NPD191 Approved
0.6783 Remote Similarity NPD7095 Approved
0.6779 Remote Similarity NPD1549 Phase 2
0.6776 Remote Similarity NPD6799 Approved
0.6776 Remote Similarity NPD7212 Phase 2
0.6776 Remote Similarity NPD7213 Phase 3
0.6765 Remote Similarity NPD1182 Approved
0.6765 Remote Similarity NPD1894 Discontinued
0.6763 Remote Similarity NPD9717 Approved
0.6757 Remote Similarity NPD1551 Phase 2
0.6752 Remote Similarity NPD1934 Approved
0.6752 Remote Similarity NPD6801 Discontinued
0.6747 Remote Similarity NPD7007 Discovery
0.6744 Remote Similarity NPD3134 Approved
0.6738 Remote Similarity NPD1819 Approved
0.6738 Remote Similarity NPD1818 Approved
0.6738 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6738 Remote Similarity NPD1817 Approved
0.6738 Remote Similarity NPD1820 Approved
0.6738 Remote Similarity NPD1203 Approved
0.6736 Remote Similarity NPD3268 Approved
0.6736 Remote Similarity NPD3056 Clinical (unspecified phase)
0.6733 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6733 Remote Similarity NPD4237 Approved
0.6733 Remote Similarity NPD4236 Phase 3
0.6732 Remote Similarity NPD3536 Discontinued
0.6715 Remote Similarity NPD6382 Discontinued
0.6715 Remote Similarity NPD5585 Approved
0.6714 Remote Similarity NPD2982 Phase 2
0.6714 Remote Similarity NPD6583 Phase 3
0.6714 Remote Similarity NPD2983 Phase 2
0.6714 Remote Similarity NPD6582 Phase 2
0.6713 Remote Similarity NPD6832 Phase 2
0.6711 Remote Similarity NPD5756 Phase 2
0.6709 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6709 Remote Similarity NPD5773 Approved
0.6709 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6709 Remote Similarity NPD5772 Approved
0.6707 Remote Similarity NPD7240 Approved
0.6691 Remote Similarity NPD1535 Discovery
0.6689 Remote Similarity NPD2154 Approved
0.6689 Remote Similarity NPD2156 Approved
0.6689 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6689 Remote Similarity NPD4108 Discontinued
0.6689 Remote Similarity NPD2155 Approved
0.6689 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6688 Remote Similarity NPD6072 Discontinued
0.6688 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6387 Discontinued
0.6667 Remote Similarity NPD709 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data